Growth Metrics

AdaptHealth (AHCO) Cash & Equivalents (2018 - 2025)

AdaptHealth has reported Cash & Equivalents over the past 8 years, most recently at $106.1 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $106.1 million for Q4 2025, down 3.29% from a year ago — trailing twelve months through Dec 2025 was $106.1 million (down 3.29% YoY), and the annual figure for FY2025 was $106.1 million, down 3.29%.
  • Cash & Equivalents for Q4 2025 was $106.1 million at AdaptHealth, up from $80.4 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for AHCO hit a ceiling of $336.7 million in Q3 2021 and a floor of $45.1 million in Q2 2023.
  • Median Cash & Equivalents over the past 5 years was $100.8 million (2023), compared with a mean of $107.0 million.
  • Biggest five-year swings in Cash & Equivalents: surged 174.35% in 2021 and later plummeted 69.08% in 2022.
  • AdaptHealth's Cash & Equivalents stood at $149.6 million in 2021, then plummeted by 69.08% to $46.3 million in 2022, then surged by 66.69% to $77.1 million in 2023, then soared by 42.28% to $109.7 million in 2024, then decreased by 3.29% to $106.1 million in 2025.
  • The last three reported values for Cash & Equivalents were $106.1 million (Q4 2025), $80.4 million (Q3 2025), and $68.6 million (Q2 2025) per Business Quant data.